Cargando…

Predicting outcomes in hyperthyroid cats treated with radioiodine

BACKGROUND: Radioiodine ((131)I) is the treatment of choice for cats with hyperthyroidism. After (131)I, however, euthyroidism is not always achieved, with 5% to 10% of cats remaining persistently hyperthyroid and 20% to 50% developing iatrogenic hypothyroidism. OBJECTIVES: To identify pretreatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Peterson, Mark E., Rishniw, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783366/
https://www.ncbi.nlm.nih.gov/pubmed/34817910
http://dx.doi.org/10.1111/jvim.16319
_version_ 1784638525583392768
author Peterson, Mark E.
Rishniw, Mark
author_facet Peterson, Mark E.
Rishniw, Mark
author_sort Peterson, Mark E.
collection PubMed
description BACKGROUND: Radioiodine ((131)I) is the treatment of choice for cats with hyperthyroidism. After (131)I, however, euthyroidism is not always achieved, with 5% to 10% of cats remaining persistently hyperthyroid and 20% to 50% developing iatrogenic hypothyroidism. OBJECTIVES: To identify pretreatment factors that may help predict persistent hyperthyroidism and iatrogenic hypothyroidism after treatment of cats using a novel (131)I dosing algorithm. ANIMALS: One thousand and four hundred hyperthyroid cats treated with (131)I. METHODS: Prospective, before‐and‐after study. Pretreatment predictors (clinical, laboratory, scintigraphic, (131)I dose, (131)I uptake measurements) of treatment failure or iatrogenic hypothyroidism were identified by multivariable logistic regression analysis. RESULTS: Cats that developed iatrogenic hypothyroidism were more likely to be older (odds ratio [OR] = 1.10; 95% confidence interval [CI], 1.04‐1.17; P = .001), female (OR = 2.04; 95% CI, 1.54‐2.70; P < .001), have detectable serum thyroid‐stimulating hormone (TSH) concentrations (OR = 4.19; 95% CI, 2.0‐8.81; P < .001), have bilateral thyroid nodules (OR = 1.57; 95% CI, 1.19‐2.08; P < .001), have homogeneous, bilateral distribution of (99m)Tc‐pertechnetate uptake (OR = 2.93; 95% CI, 2.05‐4.19; P < .001), have milder severity score (OR = 0.62; 95% CI, 0.49‐0.79; P < .001), and have higher (131)I uptake (OR = 2.40; 95% CI, 1.75‐3.28; P < .001). In contrast, cats remaining persistently hyperthyroid were more likely to be younger (OR = 0.81; 95% CI, 0.72‐0.92; P < .001), have higher severity score (OR = 1.87; 95% CI, 1.51‐2.31; P < .001), and have lower (131)I uptake (OR = 3.50; 95% CI, 1.8‐6.80; P < .001). CONCLUSIONS AND CLINICAL IMPORTANCE: Age, sex, serum TSH concentration, bilateral and homogeneous (99m)Tc‐pertechnetate uptake on scintigraphy, severity score, and percent (131)I uptake are all factors that might help predict outcome of (131)I treatment in hyperthyroid cats. Cats with persistent hyperthyroidism had many predictive factors that directly contrasted those of cats that developed (131)I‐induced hypothyroidism.
format Online
Article
Text
id pubmed-8783366
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-87833662022-02-01 Predicting outcomes in hyperthyroid cats treated with radioiodine Peterson, Mark E. Rishniw, Mark J Vet Intern Med SMALL ANIMAL BACKGROUND: Radioiodine ((131)I) is the treatment of choice for cats with hyperthyroidism. After (131)I, however, euthyroidism is not always achieved, with 5% to 10% of cats remaining persistently hyperthyroid and 20% to 50% developing iatrogenic hypothyroidism. OBJECTIVES: To identify pretreatment factors that may help predict persistent hyperthyroidism and iatrogenic hypothyroidism after treatment of cats using a novel (131)I dosing algorithm. ANIMALS: One thousand and four hundred hyperthyroid cats treated with (131)I. METHODS: Prospective, before‐and‐after study. Pretreatment predictors (clinical, laboratory, scintigraphic, (131)I dose, (131)I uptake measurements) of treatment failure or iatrogenic hypothyroidism were identified by multivariable logistic regression analysis. RESULTS: Cats that developed iatrogenic hypothyroidism were more likely to be older (odds ratio [OR] = 1.10; 95% confidence interval [CI], 1.04‐1.17; P = .001), female (OR = 2.04; 95% CI, 1.54‐2.70; P < .001), have detectable serum thyroid‐stimulating hormone (TSH) concentrations (OR = 4.19; 95% CI, 2.0‐8.81; P < .001), have bilateral thyroid nodules (OR = 1.57; 95% CI, 1.19‐2.08; P < .001), have homogeneous, bilateral distribution of (99m)Tc‐pertechnetate uptake (OR = 2.93; 95% CI, 2.05‐4.19; P < .001), have milder severity score (OR = 0.62; 95% CI, 0.49‐0.79; P < .001), and have higher (131)I uptake (OR = 2.40; 95% CI, 1.75‐3.28; P < .001). In contrast, cats remaining persistently hyperthyroid were more likely to be younger (OR = 0.81; 95% CI, 0.72‐0.92; P < .001), have higher severity score (OR = 1.87; 95% CI, 1.51‐2.31; P < .001), and have lower (131)I uptake (OR = 3.50; 95% CI, 1.8‐6.80; P < .001). CONCLUSIONS AND CLINICAL IMPORTANCE: Age, sex, serum TSH concentration, bilateral and homogeneous (99m)Tc‐pertechnetate uptake on scintigraphy, severity score, and percent (131)I uptake are all factors that might help predict outcome of (131)I treatment in hyperthyroid cats. Cats with persistent hyperthyroidism had many predictive factors that directly contrasted those of cats that developed (131)I‐induced hypothyroidism. John Wiley & Sons, Inc. 2021-11-24 2022 /pmc/articles/PMC8783366/ /pubmed/34817910 http://dx.doi.org/10.1111/jvim.16319 Text en © 2021 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals LLC on behalf of American College of Veterinary Internal Medicine. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle SMALL ANIMAL
Peterson, Mark E.
Rishniw, Mark
Predicting outcomes in hyperthyroid cats treated with radioiodine
title Predicting outcomes in hyperthyroid cats treated with radioiodine
title_full Predicting outcomes in hyperthyroid cats treated with radioiodine
title_fullStr Predicting outcomes in hyperthyroid cats treated with radioiodine
title_full_unstemmed Predicting outcomes in hyperthyroid cats treated with radioiodine
title_short Predicting outcomes in hyperthyroid cats treated with radioiodine
title_sort predicting outcomes in hyperthyroid cats treated with radioiodine
topic SMALL ANIMAL
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783366/
https://www.ncbi.nlm.nih.gov/pubmed/34817910
http://dx.doi.org/10.1111/jvim.16319
work_keys_str_mv AT petersonmarke predictingoutcomesinhyperthyroidcatstreatedwithradioiodine
AT rishniwmark predictingoutcomesinhyperthyroidcatstreatedwithradioiodine